Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xad4
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 67M | $55M | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 52M | $43M | 0% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 47M | $39M | -11% | Mar 2024 |
|
| Aristeia Capital | 31M | $25M | -25% | Mar 2024 |
|
| Point72 Asset Management | 29M | $24M | 57% | Mar 2024 |
|
| Weiss Asset Management LP[1 | 26M | $22M | -48% | Mar 2024 |
|
| FMR | 26M | $21M | -4% | Mar 2024 |
|
| Ameriprise Financial | 26M | $21M | -12% | Mar 2024 |
|
| MacKay Shields | 19M | $16M | 100% | Mar 2024 |
|
| Laurion Capital Management | 19M | $16M | 0% | Mar 2024 |
|
| Nuveen Asset Management | 19M | $15M | 100% | Mar 2024 |
|
| Aequim Alternative Investments | 15M | $12M | 0% | Mar 2024 |
|
| CNH Partners | 14M | $12M | 100% | Mar 2024 |
|
| Wells Fargo & Company | 12M | $10M | -26% | Mar 2024 |
|
| Bank of America Corporation | 12M | $9.7M | 49% | Mar 2024 |
|
| Sona Asset Management | 12M | $9.5M | 100% | Mar 2024 |
|
| Calamos Advisors | 10M | $8.2M | 0% | Mar 2024 |
|
| Lord, Abbett & Co | 9.9M | $8.2M | 19% | Mar 2024 |
|
| New York State Common Retirement Fund | 5.9M | $4.8M | 8% | Mar 2024 |
|
| BlackRock | 5.7M | $4.6M | 13% | Mar 2024 |
|
| Silverback Asset Management | 4.5M | $3.7M | -10% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.1M | $3.3M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 4.0M | $3.3M | 75% | Mar 2024 |
|
| Morgan Stanley | 2.8M | $2.3M | -29% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 2.5M | $2.0M | 0% | Mar 2024 |
|
| SSI Investment Management | 2.1M | $1.8M | -74% | Dec 2023 |
|
| DeepCurrents Investment Group | 1.8M | $1.8M | -90% | Mar 2024 |
|
| Palisade Capital Management | 1.5M | $1.2M | 0% | Mar 2024 |
|
| Citigroup | 1.2M | $1.0M | -65% | Mar 2024 |
|
| CSS | 1.0M | $859k | -79% | Mar 2024 |
|
| Russell Investments | 991k | $818k | -16% | Mar 2024 |
|
| Sunrise Partners Limited Partnership | 690k | $571k | 100% | Mar 2024 |
|
| Verition Fund Management | 554k | $454k | 9604% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 450k | $371k | 0% | Mar 2024 |
|
| Sei Investments | 156k | $127k | 100% | Mar 2024 |
|
| Context Capital Management | 36k | $30M | -100% | Mar 2024 |
|
| SG Americas Securities | 27k | $2.2M | 23% | Mar 2024 |
|
| Aurum Wealth Management Group | 10k | $8.5k | 0% | Dec 2023 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 56M | $42B |
| Diameter Capital Partners | Dec 2023 | 17M | $15M |
| Segantii Capital Management | Dec 2023 | 10M | $8.6M |
| Goldman Sachs Group | Dec 2023 | 5.0M | $4.2M |
| Absolute Investment Advisers | Dec 2023 | 4.6M | $3.9B |
| Capstone Investment Advisors | Dec 2023 | 2.0M | $1.7M |
| Jane Street | Dec 2023 | 700k | $583k |